| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/12/2004 | EP1417305A2 Identification of a dna variant associated with adult type hypolactasia |
| 05/12/2004 | EP1417304A2 Method and composition for inhibiting heparanase activity |
| 05/12/2004 | EP1417303A2 Kinase crystal structures |
| 05/12/2004 | EP1417302A2 Kinase crystal structures and materials and methods for kinase activation |
| 05/12/2004 | EP1417299A1 New biopesticide using gene from erwinia pyrifoliaewt 3, novel pathogen that affects asian pear trees |
| 05/12/2004 | EP1417237A1 Process for preparation of polypeptides of interest from fusion peolypeptides |
| 05/12/2004 | EP1417234A2 Recombinant anti-plasmodium falciparum antibodies |
| 05/12/2004 | EP1417233A2 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof |
| 05/12/2004 | EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/12/2004 | EP1417231A2 Modified human thymic stromal lymphopoietin |
| 05/12/2004 | EP1417229A2 Methods and compounds for the targeting of protein to exosomes |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417226A1 Derp1 and proderp1 allergen derivatives |
| 05/12/2004 | EP1417224A2 Secreted proteins |
| 05/12/2004 | EP1417221A2 Mimotope of neisseria meningitidis lipooligosaccharide and vaccines containing the same |
| 05/12/2004 | EP1417218A1 Tetrahymena metallothionein gene promoter and its use |
| 05/12/2004 | EP1417217A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 05/12/2004 | EP1417216A2 Antisense modulation of bcl2-associated x protein expression |
| 05/12/2004 | EP1417215A1 Antisense modulation of cd40 ligand expression |
| 05/12/2004 | EP1417214A2 Cancer specific oligosaccharide sequences and use thereof |
| 05/12/2004 | EP1416986A2 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 05/12/2004 | EP1416972A2 Chimeric molecules to modulate gene expression |
| 05/12/2004 | EP1416971A1 Gene transfer imaging and uses thereof |
| 05/12/2004 | EP1416969A2 Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier |
| 05/12/2004 | EP1416955A2 Identification of sortase gene |
| 05/12/2004 | EP1416954A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 05/12/2004 | EP1416952A1 Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases |
| 05/12/2004 | EP1416947A1 Fermentation medium and method |
| 05/12/2004 | EP1416791A2 An animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy |
| 05/12/2004 | EP1416789A1 Propagation of human hepatoblastoma cell in non-human animals |
| 05/12/2004 | EP1259537A4 Gene expression system based on chimeric receptors |
| 05/12/2004 | EP1147181B1 Replicative virus driven by the promoter for telomerase reverse transcriptase for use in treating cancer |
| 05/12/2004 | EP1137781B1 Mutants of rna polymerases with increased stability |
| 05/12/2004 | EP1109922B1 Method for the production of heterologous polypeptides in transformed yeast cells |
| 05/12/2004 | EP1038007B1 Mutant bacillus licheniformis alpha-amylase |
| 05/12/2004 | EP1025261A4 Compositions and methods for determining predisposition to insulin dependent diabetes mellitus |
| 05/12/2004 | EP1017847A4 Method of mapping restriction sites in polynucleotides |
| 05/12/2004 | EP1017269A4 Plant genes for sensitivity to ethylene and pathogens |
| 05/12/2004 | EP1014780A4 Method for altering storage organ composition |
| 05/12/2004 | EP1007736A4 Methods and compositions for modulating melting temperatures of nucleic acids |
| 05/12/2004 | EP1003908A4 Nucleic acid archiving |
| 05/12/2004 | EP1003372A4 A nod factor binding protein from legume roots |
| 05/12/2004 | EP0996705A4 Attachment of unmodified nucleic acids to silanized solid phase surfaces |
| 05/12/2004 | EP0990026B1 High-activity phytase granulate |
| 05/12/2004 | EP0971731B1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 05/12/2004 | EP0970240B1 Artificial mismatch hybridization |
| 05/12/2004 | EP0914446B1 Cytochrome p450 expression in enterobacteria |
| 05/12/2004 | EP0857221A4 Optimally fluorescent oligonucleotides |
| 05/12/2004 | EP0843724B1 Solution containing chaotropic agent and process using it for isolation of dna, rna and proteins |
| 05/12/2004 | EP0833911B1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| 05/12/2004 | EP0815240B1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 05/12/2004 | EP0815114B1 Nucleic acid synthesis using photoremovable protecting groups |
| 05/12/2004 | EP0804577B1 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 05/12/2004 | EP0792156B1 Medicaments for the prevention or treatment of vascular hemorrhaging |
| 05/12/2004 | EP0785999B1 Plant transcription regulators from circovirus |
| 05/12/2004 | EP0781092B1 Nucleic acid encoding adenovirus e1a polypeptide for sensitizing tumor cells to chemotherapy or irradiation |
| 05/12/2004 | EP0607425B1 Epstein-barr virus peptides and antibodies against these peptides |
| 05/12/2004 | CN1496410A Methods |
| 05/12/2004 | CN1496405A Processer for enhanced production of pantothenate |
| 05/12/2004 | CN1496404A Materials and methods relating to protein aggregation in neurodegenerative disease |
| 05/12/2004 | CN1496403A Plant-derived molecules and genetic sequences encoding same and uses therefor |
| 05/12/2004 | CN1496401A Genes encoding proteins participating in cytokinin synthesis |
| 05/12/2004 | CN1496400A Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (HMBPA) |
| 05/12/2004 | CN1496370A Isolated GUM operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 05/12/2004 | CN1496369A Modified interferon beta with reduced immunogenicity |
| 05/12/2004 | CN1496367A Materials and methods for producing tomato yellow leaf curl virus resistance in plants |
| 05/12/2004 | CN1496268A Vesicular stromatitis virus (VSV) |
| 05/12/2004 | CN1496224A Metod of selecting anti-microbial agent and method of using the same |
| 05/12/2004 | CN1495275A Tumour diagnostic composition |
| 05/12/2004 | CN1495274A Breast cancer pre-diagnostic composition |
| 05/12/2004 | CN1495273A Estimate carcinoma of colon and rectum |
| 05/12/2004 | CN1495263A Molecular construction and method for detecting bio-chemical reaction |
| 05/12/2004 | CN1495262A Non-splicing variant of gp 350/220 |
| 05/12/2004 | CN1495261A Joint application of caffeine biosynthetic system genome |
| 05/12/2004 | CN1495259A Production of valuable compound by using chemically defined culture medium and adopting industrial scal fermentation process |
| 05/12/2004 | CN1495258A Human tissue inhibitor of metalloprotease-4 |
| 05/12/2004 | CN1495257A New recombinant xylanase capable of deriving self-anaerobic mycetes, its related sequence, expression vector and host |
| 05/12/2004 | CN1495255A Method for obtaining non-occluded baculovirus |
| 05/12/2004 | CN1495252A Prduction method of exoinulase |
| 05/12/2004 | CN1495200A New fusion protein as carrier |
| 05/12/2004 | CN1495197A G-CSF analogs composition and its preparation method |
| 05/12/2004 | CN1495195A Transgenic animal for expressing androgen receptor compound relatea protein |
| 05/12/2004 | CN1495193A Recombinant humanized anti-hepatitis B surface antigen (HBs Ag) Fab antibody and its preparaticon method |
| 05/12/2004 | CN1495192A Improving method for hydrosulfite treatment |
| 05/12/2004 | CN1495191A HNF-1 alpha gene variant with new mononucleotide polymorphism and its coded protein variant |
| 05/12/2004 | CN1495190A Polynuleotide fragment of white-spot disease baculovirus and method for detecting virus by using it |
| 05/12/2004 | CN1149293C Male tissue-perferred regulatory region and method of using same |
| 05/12/2004 | CN1149292C Expression system and application of nutritive methyl pichia pastoris |
| 05/12/2004 | CN1149291C Process for preparing recombinant proteins using highly efficient expression vector from accharomyces cerevisiae |
| 05/12/2004 | CN1149290C Novel Human Lysozyme gene, its encodling polypeptide and the method for preparing them |
| 05/12/2004 | CN1149289C Promoter from ashbya gossypii |
| 05/12/2004 | CN1149288C Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 05/12/2004 | CN1149287C Recombinant mersacidin and method for production |
| 05/12/2004 | CN1149286C Ligand polypeptides for the G-protein-coupled recetpor protein, their production and use |
| 05/12/2004 | CN1149285C Expression of ocean fish antifreeze peptide in food grade organism and its application in food products |
| 05/12/2004 | CN1149281C Kinase activating dependent cyclin protein kinases, and their uses |
| 05/12/2004 | CN1149280C Replacement therapy for dental caries |
| 05/12/2004 | CN1149224C Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 05/12/2004 | CA2433624A1 Method for gene diagnosis of bovine hsp 70 deficiency |